Cargando…
Controversies in borderline ovarian tumors
Borderline ovarian tumors (BOTs) represent about 15% to 20% of all ovarian malignancies and differ from invasive ovarian cancers (IOCs) by many characters. Historically, standard management of BOT is peritoneal washing cytology, hysterectomy, bilateral salpingo-oophorectomy, omentectomy, complete pe...
Autores principales: | Seong, Seok Ju, Kim, Da Hee, Kim, Mi Kyoung, Song, Taejong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620372/ https://www.ncbi.nlm.nih.gov/pubmed/26404125 http://dx.doi.org/10.3802/jgo.2015.26.4.343 |
Ejemplares similares
-
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022) -
Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013) -
Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature
por: Wetterwald, Laureline, et al.
Publicado: (2023) -
Borderline resectable pancreatic cancer: Certainties and controversies
por: Nappo, Gennaro, et al.
Publicado: (2021) -
Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
por: Oh, Sumin, et al.
Publicado: (2015)